Topical Recombinant Human Epidermal Growth Factor for Oral Mucositis Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

The aim of this study was to evaluate the efficacy and safety of recombinant human epidermal growth factor (rhEGF) oral spray for oral mucositis (OM) induced by intensive chemotherapy with hematopoietic stem cell transplantation. In this phase 2 study, patients were randomized to either rhEGF (50 mi...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Kim, Ji-Won, Kim, Myeong Gyu, Lee, Hyun Jung, Koh, Youngil, Kwon, Ji-Hyun, Kim, Inho, Park, Seonyang, Kim, Byoung Kook, Oh, Jung Mi, Kim, Kyung Im, Yoon, Sung-Soo
Format: Artigo
Language:Inglês
Published: Public Library of Science 2017
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5207736/
https://ncbi.nlm.nih.gov/pubmed/28045958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0168854
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items